Planar Tc99m - Sestamibi scintimammography should be considered cautiously in the axillary evaluation of breast cancer protocols: Results of an international multicenter trial

BMC Nuclear Medicine

Volumn 5, Issue , 2005, Pages

  Massardo, Teresa ^a   Alonso, Omar ^b   Llamas Ollier, Augusto ^c   Kabasakal, Levin ^d   Ravishankar, Uma ^e   Morales, Rossana ^f   Delgado, Lucía ^b   Padhy, Ajit K ^g  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c Instituto Nacional de Cancerología   (Colombia)

^d ISTANBUL UNIVERSITY   (Turkey)

^e INDRAPRASTHA APOLLO HOSPITAL   (India)

^f INSTITUTO PERUANO DE ENERGÍA NUCLEAR   (Peru)

^g INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; AXILLA; AXILLARY LYMPH NODE; BREAST CANCER; CALCULATION; CANCER INVASION; CANCER PATIENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EVALUATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OBSERVER VARIATION; PROSPECTIVE STUDY; SCINTIMAMMOGRAPHY;

EID: 24344459901     PISSN: 14712385     EISSN: 14712385     Source Type: Journal    
DOI: 10.1186/1471-2385-5-4     Document Type: Article

References (44)

1. Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F, Feig BW, Akins J, Singletary SE, Mirza NQ, Hunt KK: Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 2003, 10:1025-30.
2. Sapino A, Cassoni P, Zanon E, Fraire F, Croce S, Coluccia C, Donadio M, Bussolati G: Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 2003, 88:702-706.
3. Schillaci O, Buscombe JR: Breast scintigraphy today: indications and limitations. Eur J Nucl Med Mol Imaging 2004, 31(Suppl 1):S35-45.
4. Buscombe JR, Holloway B, Roche N, Bombardieri E: Position of nuclear medicine modalities in the diagnostic work-up of breast cancer. Q J Nucl Med Mol Imaging 2004, 48:109-18.
5. Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst 2001, 93:630-5.
6. Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E: FDG-PET for axillary lymph node staging in primary breast cancer. Eur J Nucl Med Mol Imaging 2004, 31(Suppl 1):S97-102.
7. Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB: 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 2001, 19:3516-23.
8. Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA: Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol 2004, 27:407-10.
9. Fehr MK, Hornung R, Varga Z, Burger D, Hess T, Haller U, Fink D, von Schulthess GK, Steinert HC: Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Breast J 2004, 10:89-93.
10. Leidenius M, Krogerus L, Toivonen T, Leppanen E, von Smitten K: The sensitivity of axillary staging when using sentinel node biopsy in breast cancer. Eur J Surg Oncol 2003, 29:849-53.
11. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE, ALMANAC Trialists Group: Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 2004, 40:1731-7.
12. Van Der Vegt B, Doting MH, Jager PL, Wesseling J, De Vries J: Axillary recurrence after sentinel lymph node biopsy. Eur J Surg Oncol 2004, 30:715-20.
13. Massardo T, Alonso O, Kabasakal L, Llamas-Olier A, Shankar UR, Zhu H, Delgado L, Gonzalez P, Mut F, Padhy AK: Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions. J Nucl Med 2002, 43:882-888.
14. Alonso O, Massardo T, Delgado LB, Horvath J, Kabasakal L, Llamas-Olier A, Maunda KK, Morales R, Padhy AK, Shankar UR: Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses? J Nucl Med 2001, 42:1614-21.
15. Yutani K, Shiba E, Kusuoka H, Tatsumi M, Uehara T, Taguchi T, Takai SI, Nishimura T: Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. J Comput Assist Tomogr 2000, 24:274-80.
16. Lam WW, Yang WT, Chan YL, Stewart IE, Metreweli C, King W: Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 1996, 23:498-503.
17. Cistaro A, Bonazzi G, Bello M, Bessone M, Tetti M, Villata E, Coluccia C, Bisi G, Massaioli N: Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results. Minerva Chir 1997, 52:1177-82.
18. Schillaci O, Scopinaro F, Danieli R, Tavolaro R, Cannas P, Picardi V, Colella AC: Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer. Anticancer Res 1997, 17:1607-1610.
19. Akcay MN, Akin Y, Karabag B, Ozcan O, Oren D: Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI. Clin Nucl Med 1997, 22:832-4.
20. Tolmos J, Khalkhali I, Vargas H, Stuntz M, Cutrone J, Mishkin F, Diggles L, Venegas R, Klein S: Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography. Am Surg 1997, 63:850-3.
21. Perre CI, Rutter JE, Vos PA, de Hooge P: Technetium-99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients. Eur J Surg Oncol 1997, 23:142-4.
22. Taillefer R, Robidoux A, Turpin S, Lambert R, Cantin J, Leveille J: Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. J Nucl Med 1998, 39:459-64.
23. Danielsson R, Bone B, Perbeck L, Aspelin P: Evaluation of planar scintimammography with 99mTc-MIBI in the detection of axillary lymph node metastases of breast carcinoma. Acta Radiol 1999, 40:491-5.
24. Arslan N, Ozturk E, Ilgan S, Urhan M, Karacalioglu O, Pekcan M, Tufan T, Bayhan H: 99mTc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Nucl Med Commun 1999, 20:317-25.
25. Mulero F, Nicolas F, Castellon MI, Claver MA, Abad L, Nuno de la Rosa JA: Scintigraphy with 99mTc-MIBI in the diagnosis of axillary lymph node invasion of breast cancer. Rev Esp Med Nucl 2000, 19:416-22.
26. Nishiyama Y, Yamamoto Y, Ono Y, Irie A, Yamauchi A, Satoh K, Ohkawa M: Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases. Eur J Nucl Med 2001, 28:522-8.
27. Lumachi F, Ferretti G, Povolato M, Marzola MC, Zucchetta P, Geatti O, Bui F, Brandes AA: Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection. Eur J Surg Oncol 2001, 27:256-9.
28. Chen J, Wu H, Zhou J, Hu J: Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer. Chin Med J (Engl) 2003, 116:620-4.
29. Alonso O, Martinez M, Delgado L, Lago G, Juri C, Borges AL, Lopes de Amorim MC, de Boni D, Espasandin J, Priario J: Comparison of 99mTc-MIBI scintigraphy and sentinel node biopsy in the detection of occult lymph node metastases from cutaneous melanoma. Eur J Dermatol 2003, 13:449-54.
30. Danforth DN Jr, Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J, Whatley M, Galen B, Merino M, Neumann RD: The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer. Breast Cancer Res Treat 2002, 75:135-46.
31. Horne T, Pappo I, Cohen-Pour M, Baumer M, Orda R: 99Tc(m)-tetrofosmin scintimammography for detecting breast cancer: a comparative study with 99Tc(m)-MIBI. Nucl Med Commun 2001, 22:807-11.
32. Spanu A, Schillaci O, Meloni GB, Porcu A, Cottu P, Nuvoli S, Falchi A, Chessa F, Solinas ME, Madeddu G: The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas. Int J Oncol 2002, 21:831-40.
33. Madeddu G, Spanu A: Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients. Eur J Nucl Med Mol Imaging 2004, 31(Suppl 1):S23-34.
34. Spanu A, Dettori G, Chiaramida P, Cottu P, Falchi A, Porcu A, Solinas ME, Nuvoli S, Madeddu G: The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2000, 15:81-91.
35. Spanu A, Tanda F, Dettori G, Manca A, Chessa F, Porcu A, Falchi A, Nuvoli S, Madeddu G: The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection. Q J Nucl Med 2003, 47:116-28.
36. Spanu A, Dettori G, Nuvoli S, Porcu A, Falchi A, Cottu P, Solinas ME, Scanu AM, Chessa F, Madeddu G: (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis. Eur J Nucl Med 2001, 28:1781-94.
37. Spanu A, Dettori G, Chessa F, Porcu A, Cottu P, Solinas P, Falchi A, Solinas ME, Scanu AM, Nuvoli S, Madeddu G: 99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2001, 16:501-13.
38. Mankoff D, Dunnwald L, Kinahan P: Are We Ready for Dedicated Breast Imaging Approaches? J Nucl Med 2003, 44:594-595.
39. Avril N, Dose J, Janicke F, et al.: Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol 1996, 14:1848-57.
40. Mankoff DA, Dunnwald LK, Gralow JR, et al.: Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002, 43:500-9.
41. Tseng J, Dunnwald LK, Schubert EK, Link JM, Minoshima S, Muzi M, Mankoff DA: 18F-FDG Kinetics in Locally Advanced Breast Cancer: Correlation with Tumor Blood Flow and Changes in Response to Neoadjuvant Chemotherapy. J Nucl Med 2004, 45(11):1829-37.
42. Chua B, Ung O, Taylor R, Boyages J: Is Information from Axillary Dissection Relevant to Patients with Clinically Node-Negative Breast Cancer? Breast J 2003, 9:478-84.
43. Tornai MP, Bowsher JE, Jaszczak RJ, Pieper BC, Greer KL, Hardenbergh PH, Coleman RE: Mammotomography with pinhole incomplete circular orbit SPECT. J Nucl Med 2003, 44:583-93.
44. 99mTc-sestamibi scintimammography. Semin Nucl Med 2005, 35:100-115.